Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
高級檢索
  • Sitagliptin and cardiovascular...
  • 引用
  • 發送短信
  • 推薦此
  • 打印
  • 導出紀錄
    • 導出到 RefWorks
    • 導出到 EndNoteWeb
    • 導出到 EndNote
  • Permanent link
Sitagliptin and cardiovascular outcomes in type 2 diabetes - author's reply

Sitagliptin and cardiovascular outcomes in type 2 diabetes - author's reply

書目詳細資料
Main Authors: Holman, RR, Peterson, ED
格式: Journal article
語言:English
出版: Massachusetts Medical Society 2015
  • 持有資料
  • 實物特徵
  • 相似書籍
  • 職員瀏覽

相似書籍

  • Correspondence on sitagliptin and cardiovascular outcomes in type 2 diabetes
    由: Holman, R, et al.
    出版: (2015)
  • Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply.
    由: Holman, R, et al.
    出版: (2014)
  • Effect of sitagliptin on kidney function and respective cardiovascular outcomes in type 2 diabetes: Outcomes from TECOS.
    由: Cornel, J, et al.
    出版: (2016)
  • Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - authors' reply
    由: Nazarzadeh, M, et al.
    出版: (2022)
  • Assessing the safety of sitagliptin in older participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
    由: Bethel, M, et al.
    出版: (2017)

檢索選項

  • 檢索歷史
  • 高級檢索

查找更多

  • 瀏覽目錄
  • 按字母順序瀏覽
  • Explore Channels
  • 課程儲備
  • 新項目

需要幫助?

  • 檢索技巧
  • 咨詢台
  • 常見問題